In the MMTV-PyMT transgenic mouse model, the genetic deficiency of adiponectin elevated plasma cholesterol and low-density lipoprotein (LDL) levels, as well as increased low-density lipoprotein receptor (LDLR) expression, contributing to breast cancer development. This evidence concerns the gene ADIPOQ and breast carcinoma.